Filtering by:
Colon and Rectal CancerFDA Approves a Biosimilar to Avastin for Cancer Treatment
The US Food and Drug Administration (FDA) has approved Mvasi (bevacizumab-awwb) as the first biosimilar drug for treating cancer. It works the same way as Avastin (bevacizumab).
Colorectal Cancer Death Rates Rising In Younger People – 3 Key Takeaways
If you’re younger than 50, it’s possible you haven’t thought much about getting colorectal cancer. But emerging evidence shows that you should start paying attention.
Computer Simulation Aims to Solve Colonoscopy’s Right-Side Problem
Some studies suggest that colonoscopy may not be as effective against cancers that develop in the right side of the colon. Amy Knudsen, PhD, a researcher at Massachusetts General Hospital and Harvard Medical School in Boston, Mass., is creating a computer model to help explain why this happens.
FDA Approves Keytruda (Pembrolizumab) for Any Tumor with Specific Genetic Change
The US Food and Drug Administration (FDA) has expanded the approval of the immunotherapy drug Keytruda (pembrolizumab) to include tumors with a specific genetic change regardless of cancer type.